The student of the graduation paper of the Iraqi Board (Mosul Centre) in Internal Medicine, Sandy G. Ayo, discussed the effect and safety of the drug Ibrutinib for patients with chronic lymphocytic leukaemia in the city of Mosul / Iraq on Wednesday, 9th February 2022.The aim of the research is to know the extent of the side effects of the mentioned drug for patients with chronic leukaemia in the city of Mosul.It was concluded that this drug is a treatment option for patients with chronic lymphocytic leukaemia because it has acceptable proportions of side effects, and that treatment through it at [Read More]